Researchers Build 91% Accurate Models for Post-COVID Eye Syndrome, Linking 3-Year Symptoms to T-cell Neuroinflammation
Updated
Updated · Nature.com · Jul 9
Researchers Build 91% Accurate Models for Post-COVID Eye Syndrome, Linking 3-Year Symptoms to T-cell Neuroinflammation
3 articles · Updated · Nature.com · Jul 9
Summary
A Swedish study of 100 non-hospitalized post-COVID patients and 32 controls found persistent ocular symptoms lasting 3 to 42 months, with diagnostic models identifying the condition at 77% accuracy from clinical tests alone and 91% with tear biomarkers.
Specialized exams—not routine eye checks—showed near-vision deficits, latent eye misalignment, weakened pupillary reflexes, reduced corneal nerve density and elevated mature dendritic/T cells, matching patients’ reports of disability in reading and daily vision.
Tear proteomics found 178 dysregulated proteins, including ITGB6, NFASC, CTGF, TPSAB1 and CKMT1A-CKMT1B, with patterns overlapping severe-COVID immune signatures and pointing to chronic CD4+ T-cell dysregulation.
The researchers said the findings support a post-COVID eye syndrome driven by neuroinflammation, dysautonomia and peripheral ocular neuropathy, while noting the study did not estimate prevalence and lacked a never-infected control group.
Eyes hurt after COVID but tests are normal? A tear sample may finally reveal the hidden nerve damage.
Your smartwatch can track inflammation. Could it become the first line of defense against long COVID's invisible symptoms?
The Linköping Study (2026): 78% of Mild COVID-19 Patients Experience Long-Term Ocular Neuropathy
Overview
The Linköping Study, published in July 2026, marks a major breakthrough in understanding post-COVID eye problems. It shows that many people continue to suffer from persistent discomfort and visual disturbances long after recovering from even mild COVID-19. The study found that 78% of participants had eye symptoms lasting at least a year, and 33% experienced them for two years or more. These ongoing issues were severe enough that about a third needed to take leave from work, yet only 39% had received a formal long-COVID diagnosis. This highlights the hidden and often overlooked impact of COVID-19 on eye health.